▲ Peaking
Business
Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engager
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
T-Cell
2 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about T-Cell
This hub groups 2 separate news trends connected to T-Cell, spanning September 25, 2026 through October 2, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 9 article observations and 9 source signals, led by Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
Scientists find the gene that drives T-cell exhaustion, revealing new strategy to improve immune responses
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.